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multidrug-resistance in over 90% of cases. Results from thisear Editor,
entilator-associated pneumonia (VAP) is the most signiﬁcant
osocomial infection in patients in the intensive care unit
ICU) who have been on mechanical ventilation (MV) for over
8hours, and is related to higher morbidity and mortality of
hese patients (24% to 72%).1,2 During a prospective study, 813
atients were hospitalized in the ICU of the Clinical Center of
ojvodina, Novi Sad, Republic of Serbia. All patients were on
V for over 72hours. 40% of our patients were on MV for ﬁve
o ten days. Dostanic et al.3 have obtained similar results. The
ean duration of MV was 222.3hours. There were both malend female patients, and their mean age was 55 years. VAP
as suspected in 115 patients. Microorganisms were isolated
nd identiﬁed in 82 patients. Of the total number of analyzed
Table 1 – Resistance of isolated microorganisms to the tested an
Antimicrobial drugs
Pseudomonas
aeruginosa
Acinetobacter spp.
Sa Rb S R
Amikacin 63 47 40 60
Amoxicillin and clavulanic acid 0 100 4 96
Ampicillin 0 100 0 100
Cefalexin 0 100 6 94
Cefepime 59 41 0 100
Ceftazidime 78 22 0 100
Ceftriaxone 13 87 - -
Ciproﬂoxacin 53 47 12 88
Gentamycin 50 50 10 90
Imipenem 59 41 4 96
Meropenem 75 25 44 56
Tazocin (piperacillin+ tazobactam) 78 22 4 96
Tigecycline 0 100 4 96
Trimethoprim sulfamethoxazole 3 97 0 100
a sensitive strains shown as percentage.
b resistant strains shown as percentage.patients with suspected VAP, 29% had no bacteria, 28% had
only one isolated bacteria,while the remaining 43%of patients
had polymicrobial isolates.
Testing bacterial sensitivity to antimicrobial drugs was
performed using a standard disc diffusion method by Kirby-
Bauer, according to the guidelines of the EuropeanCommittee.
All isolated microorganisms showed over 50% resistance for
amoxicillin + clavulanic acid, ampicillin, cefalexin, ceftria-
xone, and tigecyclin (Table 1).
Acinetobacter spp. was the most prevalent bacteria (65%)
in respiratory secretion of patients on MV, and it presentedtimicrobial drugs.
Isolated microorganisms
Klebsiella pneumoniae Stenotrophomonas
maltophilia
Enterobacter spp.
S R S R S R
59 41 9 91 80 20
8 92 0 100 0 100
0 100 0 100 0 100
0 100 0 100 0 100
14 86 36 64 40 60
14 86 55 45 50 50
16 84 0 100 40 60
43 57 82 18 80 20
59 41 49 51 70 30
100 0 0 100 100 0
100 0 0 100 100 0
78 22 45 55 100 0
0 100 0 100 0 100
19 81 73 27 80 20
research showed identiﬁcation of polymicrobial isolates in
43% of cases; 23% of cases presented two bacteria, 16% pre-
sented three bacteria, 3% presented four bacteria, and 1%
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presented ﬁve bacteria. Combes et al.,4 isolated two bacteria in
70% of cases; however, they found 16.7% of tribacterial cases,
similarly to our ﬁndings.
In our research, Klebsiella pneumoniae was resistant to third-
generation cephalosporins in over 80% of cases, while in a
study from Poland the resistance rate ranged from 56% to
73%.5
Themortality ratewas 68%,which is in agreementwith the
literature.1,2 Based on the data obtained, we can conclude that
the incidence of VAP at the ICU was high.
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